Pharmaceutical composition for treating myelitis and preparation method thereof

A composition and a technique for myelitis, applied in the field of pharmaceutical compositions for the treatment of myelitis, can solve problems such as large side effects of hormones, unfavorable health of patients, etc., and achieve the effect of restoring feeling

Inactive Publication Date: 2016-06-22
朱拥军
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The side effects of hormones are large, which is not good for the patient's body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0008] Embodiment 1: a kind of pharmaceutical composition for the treatment of myelitis is characterized in that it is made by the parts by weight of following raw materials: Scutellaria baicalensis 6~9 parts, Radix Puerariae 6~9 parts, Qingdai 6~9 parts, Cortex Mori 6 ~9 parts, 6~9 parts of Cangzhu, 4~6 parts of ghost needle grass, 6~9 parts of Shouwu vine, 6~9 parts of Shenjincao, 2~4 parts of Panax notoginseng, 6~9 parts of Daxueteng, maple 2 to 4 parts of balsam, 4 to 6 parts of clove, 6 to 9 parts of Achyranthes bidentata, 6 to 9 parts of psoralen, 2 to 4 parts of Anemarrhena, 6 to 9 parts of Smilax, and 6 to 9 parts of licorice. The production method is the same as above.

Embodiment 2

[0009] Embodiment 2: a kind of pharmaceutical composition for the treatment of myelitis is characterized in that it is made by the parts by weight of following crude drugs: 9 parts of Radix Scutellariae, 6 parts of Radix Puerariae, 4 parts of Indigo Daisy, 9 parts of Cortex Mori, 6 parts of Atractylodes Rhizome, 4 parts of ghost needle grass, 9 parts of Shouwu vine, 9 parts of Shenjincao, 2 parts of Panax notoginseng, 9 parts of Daxueteng, 2 parts of maple resin, 6 parts of clove, 9 parts of Achyranthes bidentata, 6 parts of psoralen, 4 parts of mother, 9 parts of Smilax smilax, 6 parts of licorice. The preparation method is the same as in Example 1 to obtain the ointment. 10g per bag.

[0010] One. Case selection: 52 patients treated by the present invention were diagnosed by hospitals above the county level, including 34 males and 18 females, aged 16-45 years, with an average age of 31.6 years; the course of disease was 1-15 days, with an average of 5.81 days.

[0011] 2. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a pharmaceutical composition for treating myelitis and a preparation method thereof, which is characterized in that it is made of the following raw materials in parts by weight: 6-9 parts of Scutellaria baicalensis, 6-9 parts of Pueraria lobata, 6-9 parts of Qingdai, and Mori Bai 6-9 parts of skin, 6-9 parts of Cangzhu, 4-6 parts of ghost needle grass, 6-9 parts of Shouwu vine, 6-9 parts of Shenjincao, 2-4 parts of Panax notoginseng, 6-9 parts of Daxueteng , 2-4 parts of maple gum, 4-6 parts of clove, 6-9 parts of Achyranthes bidentata, 6-9 parts of psoralen, 2-4 parts of Anemarrhena, 6-9 parts of Smilax, 6-9 parts of licorice. The beneficial effect of the invention is that: by extracting the active ingredients of the traditional Chinese medicine, the functions of sensory and motor nerves are restored, and the effects of clearing away heat and eliminating plague, promoting blood circulation and promoting qi, expelling wind and dampness, relieving spasm and relieving pain are achieved.

Description

[0001] Technical Field The present invention relates to a pharmaceutical composition and a preparation method for treating myelitis. Background technique [0002] The disease is caused by exogenous pathogenic factors, and is mainly caused by feeling warm and toxic. A disease caused by an infection or toxin invading the spinal cord. Because the lesions in the spinal cord are often transverse, it is also called transverse myelitis. Acute myelitis caused by viral infection mostly occurs in young adults, with no gender difference, sporadic and rapid onset. Most of them have mild prodromal symptoms, such as low-grade fever, general malaise, or symptoms of upper respiratory tract infection. Myelitis refers to the inflammatory lesions of the gray matter or (and) white matter of the polio cord caused by viruses, bacteria, spirochetes, rickettsias, parasites, protozoa, mycoplasma, etc. Limb paralysis, sensory impairment and autonomic dysfunction are its clinical features. Cold, ove...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8964A61K36/90A61P25/28A61P31/04A61P31/12
CPCA61K36/539A61K9/06A61K36/11A61K36/185A61K36/195A61K36/21A61K36/258A61K36/28A61K36/284A61K36/315A61K36/484A61K36/487A61K36/488A61K36/605A61K36/61A61K36/704A61K36/896A61K36/8964A61K36/90A61K47/40A61K2236/331A61K2236/333A61K2236/39A61K2236/51A61K2236/53
Inventor 朱拥军于丽群
Owner 朱拥军
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap